Print Page  Close Window

Investor Relations


Zogenix, Inc. (Nasdaq: ZGNX) is a pharmaceutical company committed to developing and commercializing CNS therapies that address specific clinical needs for people living with orphan and other CNS disorders who need innovative treatment alternatives to improve their daily functioning.
NASDAQ | ZGNX (Common Stock)
$9.33 + 0.04
Stock chart for: ZGNX.O.  Currently trading at $9.33 with a 52 week high of $21.03 and a 52 week low of $7.33.
Data as of 08/29/16 4:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.

Latest Presentations

Zogenix July 2016 Investor Presentation
Download Documentation

Recent News More

Zogenix Provides Corporate Update and Reports Second Quarter 2016 Financial Results

Read More

Zogenix to Release Second Quarter 2016 Financial Results and Host Conference Call and Webcast on August 9

Read More

Investor Events More

Tuesday, June 7, 2016 9:30 a.m. ET
Zogenix, Inc. at Jefferies 2016 Healthcare Conference
Tuesday, May 10, 2016 4:30 p.m. ET
Q1 2016 Zogenix, Inc. Earnings Conference Call